A focused review finds that antibody–drug conjugates directly kill breast-cancer cells, while evidence that they remodel ...
Simcere Zaiming Pharmaceutical Co. Ltd. has announced clinical trial approvals in China and the U.S. for its CDH6-targeting antibody-drug conjugate (ADC), SIM-0505, for advanced solid tumors. A global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results